Cerenome, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.2M | $5.8M | $4.9M | $3.7M | $2.7M | $4.7M | $4.8M | $5.0M |
| Cost of Revenue | — | — | — | $1.1M | $1.3M | $2.7M | $3.2M | $2.9M |
| Gross Profit | — | — | — | $2.5M | $146.0K | $1.9M | $1.7M | $2.0M |
| Gross Margin | — | — | — | 68.7% | 5.4% | 41.7% | 34.1% | 40.6% |
| Operating Expenses | ||||||||
| Research & Development | $8.4M | $10.6M | $9.7M | $5.5M | $11.7M | $16.2M | $19.0M | $15.1M |
| SG&A Expense | $12.1M | $9.9M | $8.5M | $5.6M | $7.6M | $8.6M | $9.8M | $16.0M |
| Operating Income | $-15.3M | $-14.7M | $-13.3M | $-8.8M | $-20.7M | $-19.7M | $-15.3M | $-32.4M |
| Operating Margin | -293.5% | -252.3% | -271.1% | -238.7% | -769.2% | -423.2% | -316.0% | -654.9% |
| Interest Expense | — | — | $395.0K | $1.9M | $2.0M | $2.6M | $3.4M | $4.4M |
| Pretax Income | $-22.4M | $-13.0M | — | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Net Income | $-22.4M | $-13.0M | $-13.3M | $-12.6M | $-22.7M | $-22.0M | $-18.7M | $-37.4M |
| Net Margin | -429.4% | -222.8% | -271.0% | -344.2% | -843.7% | -473.5% | -387.4% | -754.5% |
| EPS (Basic) | $-0.29 | $-1.95 | $-0.42 | $-8.70 | $-0.82 | $-0.13 | $-0.21 | $-0.05 |
| EPS (Diluted) | $-0.29 | $-2.34 | $-0.42 | $-8.70 | $-0.82 | $-0.13 | $-0.21 | $-0.05 |
| Shares Outstanding (Basic) | 77.8M | 6.6M | 31.4M | 3.0M | 57.8M | 217.1M | 130.0M | 993.5M |
| Shares Outstanding (Diluted) | 77.8M | 7.7M | 31.4M | 3.0M | 57.8M | 217.1M | 130.0M | 993.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |